{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:55:22Z","timestamp":1782298522719,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 30872950"],"award-info":[{"award-number":["NO. 30872950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.82201817"],"award-info":[{"award-number":["NO.82201817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic scientific research project of Liaoning Provincial Department of Education","award":["LJKMZ20221290"],"award-info":[{"award-number":["LJKMZ20221290"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04323-1","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:17:59Z","timestamp":1777547879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artesunate directly targeting MMP9 to reduce angiogenesis and increase CD8\u2009+\u2009T cell infiltration inhibits hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"4323_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4323_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12957-016-0912-7","volume":"14","author":"S Yang","year":"2016","unstructured":"Yang S, Lin Q, Lin W, Hu W, Wang G. Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review. World J Surg Oncol. 2016;14(1):159.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4323_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"20","key":"4323_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"10","key":"4323_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/cid\/ciab133","volume":"73","author":"C Roussel","year":"2021","unstructured":"Roussel C, Ndour PA, Kendjo E, Larreche S, Taieb A, Henry B, Lebrun-Vignes B, Chambrion C, Argy N, Houze S, et al. Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 Patients. Clin Infect Dis. 2021;73(10):1795\u2013804.","journal-title":"Clin Infect Dis"},{"key":"4323_CR6","doi-asserted-by":"publisher","first-page":"154259","DOI":"10.1016\/j.phymed.2022.154259","volume":"104","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li Y, Wan J, Zhang M, Li C, Lin J. Artesunate: A review of its therapeutic insights in respiratory diseases. Phytomedicine. 2022;104:154259.","journal-title":"Phytomedicine"},{"key":"4323_CR7","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","volume":"109","author":"Z Kong","year":"2019","unstructured":"Kong Z, Liu R, Cheng Y. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomed Pharmacother. 2019;109:2043\u201353.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4323_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, Yang XM, Liu YJ, Wu Y, Chen PH, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4323_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41467-024-45452-3","volume":"15","author":"X Guo","year":"2024","unstructured":"Guo X, Asthana P, Zhai L, Cheng KW, Gurung S, Huang J, Wu J, Zhang Y, Mahato AK, Saarma M, et al. Artesunate treats obesity in male mice and non-human primates through GDF15\/GFRAL signalling axis. Nat Commun. 2024;15(1):1034.","journal-title":"Nat Commun"},{"issue":"25","key":"4323_CR10","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","volume":"187","author":"H Zhang","year":"2024","unstructured":"Zhang H, Thai PN, Shivnaraine RV, Ren L, Wu X, Siepe DH, Liu Y, Tu C, Shin HS, Caudal A, et al. Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. Cell. 2024;187(25):7143\u2013e71637122.","journal-title":"Cell"},{"issue":"1","key":"4323_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41392-025-02305-9","volume":"10","author":"H Yuan","year":"2025","unstructured":"Yuan H, Li Q, Li L, Zhao G, Zhang J, Feng T, Guo Y, Kou Q, Li S, Li S, et al. DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation. Signal Transduct Target Ther. 2025;10(1):221.","journal-title":"Signal Transduct Target Ther"},{"key":"4323_CR12","doi-asserted-by":"publisher","first-page":"156333","DOI":"10.1016\/j.phymed.2024.156333","volume":"136","author":"Y Wei","year":"2025","unstructured":"Wei Y, Liu F, Zhu X, Liu X, Li H, Hou L, Ma X, Li F, Liu H. Artesunate disrupts ribosome RNA biogenesis and inhibits ovarian cancer growth by targeting FANCA. Phytomedicine. 2025;136:156333.","journal-title":"Phytomedicine"},{"issue":"2","key":"4323_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.21037\/jgo-2025-95","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wu J, Li Z, Wu Z, Li S, Yang G, Rong X, Wang Q, Li Y, Xia Q, et al. Inhibition of hepatocellular carcinoma progression by artesunate via modulation of the TLR4\/MyD88\/NF-kappaB signaling pathway. J Gastrointest Oncol. 2025;16(2):599\u2013614.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"4323_CR14","first-page":"595","volume":"2","author":"F Pezzella","year":"2019","unstructured":"Pezzella F. Mechanisms of resistance to anti-angiogenic treatments. Cancer Drug Resist. 2019;2(3):595\u2013607.","journal-title":"Cancer Drug Resist"},{"key":"4323_CR15","doi-asserted-by":"publisher","first-page":"454783","DOI":"10.1155\/2013\/454783","volume":"2013","author":"B Krusche","year":"2013","unstructured":"Krusche B, Arend J, Efferth T. Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo. Evid Based Complement Alternat Med. 2013;2013:454783.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4323_CR16","doi-asserted-by":"crossref","unstructured":"Ding H, Hu H, Tian F, Liang H. A dual immune signature of CD8\u2009+\u2009T cells and MMP9 improves the survival of patients with hepatocellular carcinoma. Biosci Rep 2021, 41(3) :BSR20204219.","DOI":"10.1042\/BSR20204219"},{"key":"4323_CR17","doi-asserted-by":"publisher","first-page":"620594","DOI":"10.3389\/fgene.2021.620594","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li H, Dong J, Zhang N, Liu Y, Luo X, Chen J, Wang J, Wang A. Omics-Based Identification of Shared and Gender Disparity Routes in Hras12V-Induced Hepatocarcinogenesis: An Important Role for Dlk1-Dio3 Genomic Imprinting Region. Front Genet. 2021;12:620594.","journal-title":"Front Genet"},{"issue":"1","key":"4323_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","volume":"5","author":"Y Xue","year":"2024","unstructured":"Xue Y, Ruan Y, Wang Y, Xiao P, Xu J. Signaling pathways in liver cancer: pathogenesis and targeted therapy. Mol Biomed. 2024;5(1):20.","journal-title":"Mol Biomed"},{"issue":"8","key":"4323_CR19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1074\/mcp.M116.065474","volume":"16","author":"Z Rong","year":"2017","unstructured":"Rong Z, Fan T, Li H, Li J, Wang K, Wang X, Dong J, Chen J, Wang F, Wang J, et al. Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice. Mol Cell Proteom. 2017;16(8):1475\u201390.","journal-title":"Mol Cell Proteom"},{"issue":"6","key":"4323_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","volume":"73","author":"N Cai","year":"2024","unstructured":"Cai N, Cheng K, Ma Y, Liu S, Tao R, Li Y, Li D, Guo B, Jia W, Liang H, et al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut. 2024;73(6):985\u201399.","journal-title":"Gut"},{"key":"4323_CR21","doi-asserted-by":"publisher","first-page":"107706","DOI":"10.1016\/j.pharmthera.2020.107706","volume":"216","author":"Y Augustin","year":"2020","unstructured":"Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing. Pharmacol Ther. 2020;216:107706.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"4323_CR22","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1002\/jcb.27889","volume":"120","author":"W Jing","year":"2019","unstructured":"Jing W, Dong H, Min M, Runpeng Z, Xuewei X, Ru C, Yingru X, Shengfa N, Baoxian T, Jinbo Y, et al. Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma. J Cell Biochem. 2019;120(4):6026\u201334.","journal-title":"J Cell Biochem"},{"issue":"3","key":"4323_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jgr.2021.07.002","volume":"46","author":"YJ Chen","year":"2022","unstructured":"Chen YJ, Wu JY, Deng YY, Wu Y, Wang XQ, Li AS, Wong LY, Fu XQ, Yu ZL, Liang C. Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models. J Ginseng Res. 2022;46(3):418\u201325.","journal-title":"J Ginseng Res"},{"issue":"2","key":"4323_CR24","doi-asserted-by":"publisher","first-page":"152795","DOI":"10.1016\/j.prp.2019.152795","volume":"216","author":"HN Fan","year":"2020","unstructured":"Fan HN, Zhu MY, Peng SQ, Zhu JS, Zhang J, Qu GQ. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling. Pathol Res Pract. 2020;216(2):152795.","journal-title":"Pathol Res Pract"},{"key":"4323_CR25","doi-asserted-by":"crossref","unstructured":"Lin L, Tang Z, Shi Z, Guo Q, Xiong H. New Insights into Artesunate as a Pleiotropic Regulator of Innate and Adaptive Immune Cells. J Immunol Res 2022, 2022:9591544.","DOI":"10.1155\/2022\/9591544"},{"issue":"1","key":"4323_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s40001-024-01882-9","volume":"29","author":"L Mao","year":"2024","unstructured":"Mao L, Deng G, Li M, Lu SH, Jiang W, Yu X. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells. Eur J Med Res. 2024;29(1):293.","journal-title":"Eur J Med Res"},{"key":"4323_CR27","doi-asserted-by":"crossref","unstructured":"Tian LY, Smit DJ, Jucker M. The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int J Mol Sci 2023, 24(3) :2652.","DOI":"10.3390\/ijms24032652"},{"issue":"2","key":"4323_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s43440-021-00230-6","volume":"73","author":"M Berkoz","year":"2021","unstructured":"Berkoz M, Ozkan-Yilmaz F, Ozluer-Hunt A, Krosniak M, Turkmen O, Korkmaz D, Keskin S. Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway. Pharmacol Rep. 2021;73(2):650\u201363.","journal-title":"Pharmacol Rep"},{"issue":"5\u20137","key":"4323_CR29","doi-asserted-by":"publisher","first-page":"152174","DOI":"10.1016\/j.acthis.2024.152174","volume":"126","author":"QY Ma","year":"2024","unstructured":"Ma QY, Xu XY, Zhu YZ, Yao NN, Liu YC, Gao XD, Zhang Q, Luo WJ. Artesunate inhibits vasculogenic mimicry in choroidal melanoma through HIF-1 alpha\/ VEGF\/PDGF pathway. Acta Histochem. 2024;126(5\u20137):152174.","journal-title":"Acta Histochem"},{"key":"4323_CR30","doi-asserted-by":"crossref","unstructured":"Chen Y, Tao H, Wang F, Wu P, Gao J, Zhang X, He Z, Zhou Z, Jia Y. Artesunate synergistically promotes sorafenib\u2013induced apoptosis and ferroptosis in non\u2013Hodgkin lymphoma cells through inhibition of the STAT3 pathway. Oncol Rep 2023, 50(1) :147","DOI":"10.3892\/or.2023.8584"},{"issue":"2\u20133","key":"4323_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","volume":"47","author":"HJ Zhou","year":"2007","unstructured":"Zhou HJ, Wang WQ, Wu GD, Lee J, Li A. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol. 2007;47(2\u20133):131\u20138.","journal-title":"Vascul Pharmacol"},{"issue":"45","key":"4323_CR32","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","volume":"20","author":"S Sharma","year":"2014","unstructured":"Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol. 2014;20(45):16820\u201330.","journal-title":"World J Gastroenterol"},{"key":"4323_CR33","doi-asserted-by":"publisher","first-page":"156498","DOI":"10.1016\/j.phymed.2025.156498","volume":"140","author":"RY Shang","year":"2025","unstructured":"Shang RY, Yang JC, Hu WG, Xiao R, Hu DS, Lin ZC, Li S, Wang NN, Zheng Y, Liu ZH, et al. Artesunate attenuates skin hypertrophic scar formation by inhibiting fibroblast activation and EndMT of vascular endothelial cells. Phytomedicine. 2025;140:156498.","journal-title":"Phytomedicine"},{"issue":"10","key":"4323_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000;2(10):737\u201344.","journal-title":"Nat Cell Biol"},{"issue":"13","key":"4323_CR35","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ejca.2008.06.031","volume":"44","author":"LJ Hawinkels","year":"2008","unstructured":"Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, Fontijn RD, David G, Hommes DW, Lamers CB, et al. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer. 2008;44(13):1904\u201313.","journal-title":"Eur J Cancer"},{"issue":"11","key":"4323_CR36","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.devcel.2021.05.001","volume":"56","author":"D Inverso","year":"2021","unstructured":"Inverso D, Shi J, Lee KH, Jakab M, Ben-Moshe S, Kulkarni SR, Schneider M, Wang G, Komeili M, Velez PA, et al. A spatial vascular transcriptomic, proteomic, and phosphoproteomic atlas unveils an angiocrine Tie-Wnt signaling axis in the liver. Dev Cell. 2021;56(11):1677\u201393. e1610.","journal-title":"Dev Cell"},{"key":"4323_CR37","doi-asserted-by":"publisher","first-page":"1190333","DOI":"10.3389\/fimmu.2023.1190333","volume":"14","author":"J Han","year":"2023","unstructured":"Han J, Wu M, Liu Z. Dysregulation in IFN-gamma signaling and response: the barricade to tumor immunotherapy. Front Immunol. 2023;14:1190333.","journal-title":"Front Immunol"},{"issue":"15","key":"4323_CR38","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-17-2176","volume":"78","author":"L Meder","year":"2018","unstructured":"Meder L, Schuldt P, Thelen M, Schmitt A, Dietlein F, Klein S, Borchmann S, Wennhold K, Vlasic I, Oberbeck S, et al. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018;78(15):4270\u201381.","journal-title":"Cancer Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04323-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:06:03Z","timestamp":1782169563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04323-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4323"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04323-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of Dalian Medical University (Approval No. AEE24341), and the study was conducted in agreement with the guidelines set forth by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}